Bio-IT World August 6, 2020
Contributed Commentary by Josh Gluck

We’ve learned so much living through these unprecedented times. One lesson is the need to mobilize quickly, provide effective testing and contact tracing, and accelerate the development of therapies and vaccines to protect the global community. The issue is not simply one of speed; it’s more complex than that. We must also enable smarter development cycles with innovative approaches that provide the most expeditious, cost-effective, and, ultimately, safest path forward.

That can only be done through the power of data: the defining currency in drug discovery and clinical development. We need to be able to leverage more of it, faster, and more completely than ever before to shave time off the drug discovery and development time frame.

Artificial intelligence (AI)...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Public Health / COVID, Technology
ONC @ 20: A Tale of Optimism and Humility
Europe Strengthens Future Disease Defense
HIV Transmission Linked To Vampire Facials, Says CDC
Early tests of H5N1 prevalence in milk suggest U.S. bird flu outbreak in cows is widespread
Bird Flu (H5N1) Explained: Here’s What To Know—And Why Scientists Are Concerned

Share This Article